Study guide
10.3 Botulism and Presynaptic Toxin Patterns
Registered Nerve Conduction Studies Technologist R.NCS.T.
Track your progress as you read
Finished sections get a check mark.
1 Exam Overview
1.1 Current Exam Facts 1.2 Eligibility, Documentation, and Application 1.3 Scoring, Recertification, and Test Day
2 Membrane Physiology and Action Potentials
2.1 Resting Membrane Potential and Cell Membrane Physiology 2.2 Action Potential Phases, All-or-None Response, and Refractory Periods 2.3 Saltatory Conduction, Myelin, and Nodes of Ranvier
3 Peripheral Nerve Structure and Cell Bodies
3.1 Fascicles and Nerve Connective Tissues 3.2 Peripheral Nerve Fiber Types 3.3 Motor and Sensory Cell-Body Locations
4 Muscle Physiology, Roots, and Plexuses
4.1 Skeletal Muscle Structure: Myofibrils, Sarcomeres, and Bands 4.2 Excitation-Contraction Coupling 4.3 Spinal Roots, Dorsal and Ventral Roots, and Rami 4.4 Brachial and Lumbosacral Plexus Organization
5 Electronics, Instrumentation, and Stimulation
5.1 Ohm’s Law, AC/DC Circuits, and Resistance 5.2 Amplifiers, Filters, Averaging, and Display Settings 5.3 Stimulators, Polarity, and Stimulation Pitfalls
6 Waveform Parameters, Conduction Velocity, and Pediatric NCS
6.1 Latency, Amplitude, Duration, Area, and Rise Time 6.2 Conduction Velocity Calculation and Normal Values 6.3 Pediatric Nerve Conduction Studies
7 Lesion Patterns and Wallerian Degeneration
7.1 Preganglionic versus Postganglionic Lesions 7.2 Focal Lesions, Conduction Block, Demyelination, and Temporal Dispersion 7.3 Axonal Loss, Wallerian Degeneration, and Nerve-Injury Grades
8 Late Responses and the Blink Reflex
8.1 F Waves: Origin, Technique, and Clinical Use 8.2 H Reflexes: Origin, Technique, and Clinical Use 8.3 A Waves and the Blink Reflex
9 NMJ Physiology and Repetitive Nerve Stimulation
9.1 Neuromuscular Junction Anatomy and Physiology 9.2 Repetitive Nerve Stimulation: Technical Setup 9.3 Post-Activation Facilitation, Exhaustion, and Pseudofacilitation
10 Neuromuscular Junction Disorders
10.1 Myasthenia Gravis (Postsynaptic) 10.2 Lambert-Eaton Myasthenic Syndrome 10.3 Botulism and Presynaptic Toxin Patterns
11 Upper-Extremity Nerve Conduction Protocols
11.1 Median Motor, Sensory, AIN, and Palmar Cutaneous Studies 11.2 Ulnar Motor, Sensory, Dorsal Ulnar Cutaneous, and Medial Antebrachial Studies 11.3 Radial Motor, Posterior Interosseous, and Superficial Radial Studies
12 Upper-Extremity Entrapments and Mononeuropathies
12.1 Median Neuropathy at the Wrist (Carpal Tunnel) 12.2 Ulnar Neuropathy at the Elbow and Guyon’s Canal 12.3 Radial Neuropathy (Saturday Night Palsy) and Related UE Mononeuropathies
13 Lower-Extremity Nerve Conduction Protocols
13.1 Common, Deep, and Superficial Fibular (Peroneal) Studies 13.2 Tibial Motor and Medial/Lateral Plantar Studies 13.3 Sural, Saphenous, and Lateral Femoral Cutaneous Studies
14 Lower-Extremity Neuropathies and Proximal Nerves
14.1 Fibular Neuropathy at the Fibular Head versus L5 Radiculopathy 14.2 Tarsal Tunnel, Tibial Neuropathy, and S1 Localization 14.3 Femoral, Sciatic, and Lateral Femoral Cutaneous Neuropathies
15 Cranial Nerves, Other Nerves, and Plexus Lesions
15.1 Cranial Nerves with Facial, Trigeminal, and Accessory Studies 15.2 Phrenic, Suprascapular, Long Thoracic, and Axillary Nerves 15.3 Plexus Lesions: Erb’s Palsy, Neurogenic TOS, and Parsonage-Turner
16 Root, Motor Neuron, Polyneuropathy, and Muscle Disorders
16.1 Radiculopathy, Root Avulsion, and Sensory Neuronopathy 16.2 Motor Neuron Disease and Multifocal Motor Neuropathy 16.3 Polyneuropathies, Mononeuropathy Multiplex, and Muscle Disorders
17 Temperature, Age, Height, and Martin-Gruber Anastomosis
17.1 Temperature Effects and Warming Methods 17.2 Age and Height Effects on Nerve Conduction 17.3 Martin-Gruber Anastomosis Patterns
18 Anomalous Innervation, Technical Factors, and Safety
18.1 Riche-Cannieu Anastomosis and Accessory Fibular Nerve 18.2 Technical Factors and Troubleshooting Abnormal Studies 18.3 Infection Control, Electrical Safety, HIPAA, and OSHA
10.3 Botulism and Presynaptic Toxin Patterns
Key Takeaways Explain This Topic AI
Botulinum toxin is a protease that cleaves SNARE proteins and blocks acetylcholine vesicle fusion at the presynaptic terminal (outline V.A.2.b).
Clinical forms are foodborne (preformed toxin), wound, and infant (gut colonization); descending cranial and autonomic findings, including poorly reactive pupils, are high-yield.
NCS teaching: low CMAPs, sensory SNAPs typically spared, and a modest exercise or fast-RNS increment that is often less dramatic than classic LEMS.
Three-way contrast: MG has a usually normal CMAP and little autonomic/pupil involvement; LEMS has a large increment plus VGCC antibodies and often SCLC; botulism is a toxin-SNARE story with pupils and a milder increment.
Congenital myasthenic syndromes are a brief genetic differential, not this outline item; do not expand them into a separate chapter here.
Last updated: September 2026
10.3 Botulism and Presynaptic Toxin Patterns
Quick Answer: Botulinum toxin cleaves SNARE proteins and blocks acetylcholine vesicle release . Think foodborne , wound , and infant forms. Nerve conduction teaching: low CMAPs , a modest increment with brief exercise or fast RNS ( often less dramatic than classic LEMS ), and sensory SNAPs typically spared . Pupils and autonomic findings are part of the clinical pattern. Independent ExamFinch study of outline item V.A.2.b Botulism is this toxin pattern, not a long congenital-myasthenia chapter.
Chapter 9 already covered immobilization, 2–3 Hz versus 20–50 Hz , and 10-second exercise. Reuse that toolbox. This section asks what the tracing looks like when the terminal's fusion machinery is poisoned rather than antibody-blocked at calcium channels (LEMS) or receptors (MG).
This chapter is independent study material for learners preparing for the National Registry Examination for Nerve Conduction Studies . It is not a publication of AAET and does not claim official approval, review, partnership, or exact equivalence with the handbook outline. Increment percentages below are typical electrodiagnostic teaching , not official unpublished AAET cut scores.
Mechanism: SNARE cleavage, not receptor loss
Botulinum neurotoxin (BoNT) is taken up at cholinergic terminals. The light chain is a zinc-dependent protease that cleaves SNARE proteins required for synaptic-vesicle fusion (teaching map: SNAP-25, synaptobrevin/VAMP, or syntaxin depending on serotype). Vesicles of acetylcholine cannot fuse . Quantal content collapses. The muscle never sees enough transmitter, so many fibers drop out of the CMAP at rest . The lesion is presynaptic , like LEMS, but the molecular target is the fusion complex , not the P/Q-type VGCC .
That distinction matters on written items. A stem that says "antibodies to calcium channels" is LEMS. A stem that says "toxin cleaves SNARE" or "home-canned food" or "honey and a floppy infant" is botulism. A stem that says "acetylcholine-receptor antibodies and fatigable ptosis with a normal CMAP" is MG.
Autonomic and pupillary cholinergic synapses can be hit by the same toxin family, which is why dilated, poorly reactive pupils , dry mouth , ileus , and urinary retention travel with the weakness. MG usually spares pupils . LEMS has autonomic features but is not the classic fixed-pupil descending paralysis after a tainted meal .
Clinical forms: foodborne, wound, infant
Form How toxin arrives Teaching setting NCS implication
Foodborne Preformed toxin ingested Improperly canned or preserved food; GI prodrome then descending paralysis Same NMJ pattern; history is the clue, not a special montage
Wound Toxin produced in a wound (soil, injection-drug use) Little or no GI prodrome; longer incubation Same low-CMAP presynaptic pattern
Infant Gut colonization and in-situ toxin (honey is a classic teaching association, not the only source) Constipation, weak cry, floppy infant Same physiology; patient size changes electrodes, not the synapse
Iatrogenic weakness after therapeutic or cosmetic injection is usually local . Rare systemic spread can mimic mild botulism. It is not a fourth outline category; it is the same SNARE mechanism in a smaller dose.
Descending, symmetric, cranial-first paralysis is the clinical arc: diplopia, dysarthria, dysphagia, then limbs and respiration. Mentation is typically clear (the toxin is not a primary encephalitis). Sensory symptoms are not the driver. Pupils that dilate and react poorly are a high-yield discriminator from MG.
NCS pattern: low CMAP, spared SNAP, modest increment
Record motor responses as in any NMJ protocol: warm , immobilized , supramaximal , a muscle with a reproducible CMAP . Expect:
Low CMAPs. Like LEMS, resting quantal content is too small for a full surface potential. Multiple distal muscles may look small. Do not stop at one 1 mV ADM without checking that G1 is on the motor point.
Sensory SNAPs typically spared. Botulism is not a length-dependent sensory polyneuropathy story. Present SNAPs with low CMAPs push you toward NMJ or motor-neuron/motor-axon patterns, and the increment plus pupils push you toward presynaptic toxin rather than motor neuron disease alone.
Modest increment after about 10 seconds of isometric exercise or during fast RNS (20–50 Hz) . Facilitation can occur because residual release machinery still responds somewhat to calcium accumulation, but textbook teaching is that the jump is often less dramatic than classic LEMS . The 1.5 mV → 4.0 mV ( ~167 percent ) ADM example in section 10.2 is a LEMS-sized teaching leap. A botulism tracing might move from 2.0 mV to 2.6 mV (a 30 percent increment) — enough to hint at a presynaptic problem, not enough to clone the LEMS worked example. Some patients show more; some show almost none. Do not invent an official AAET increment cutoff that "proves" botulism. Describe low CMAP + modest facilitation + spared SNAPs in the clinical context of toxin exposure and pupils.
Slow RNS may show a decrement because safety factor is gone. As in LEMS, decrement alone is not MG if the resting CMAP is tiny and the history is toxin.
Needle EMG, when a physician performs it, may show unstable motor-unit potentials or, if junctions are silent enough, fibrillation-like spontaneous activity. That is not a technologist NCS skill. Mention it only so you do not think botulism must look electrically identical to a Saturday-night radial palsy.
Three-column contrast: MG, LEMS, botulism
- Feature MG (postsynaptic) LEMS (presynaptic VGCC) Botulism (presynaptic toxin)
- Core mechanism Fewer AChR (MuSK subset) P/Q-type VGCC antibodies Toxin cleaves SNARE ; vesicles cannot fuse
- Outline map V.A.3 V.A.2.a V.A.2.b
- Typical trigger Autoimmune; thymic disease clinical SCLC or autoimmune Foodborne, wound, infant
- Pupils Typically spared Not the classic fixed-pupil meal story Dilated, poorly reactive often
- Autonomic Not the hallmark Dry mouth , other autonomic Prominent (pupils, gut, bladder, dry mouth)
Reflexes Usually preserved Hyporeflexia ; may improve after exercise Reduced when junctions fail; history still toxin
- Baseline CMAP Usually normal Low Low
- Slow RNS Decrement ; may repair then exhaust May decrement May decrement
Brief exercise / fast RNS Decrement repair ; no classic huge CMAP jump Large increment (1.5 → 4.0 mV teaching) Modest increment , often less than classic LEMS
SNAPs Typically present Typically present Typically spared
Highest-yield trap Movement or cooling; ADM-only in facial MG Calling decrement MG and missing the low CMAP Expecting a LEMS-sized increment or abnormal SNAPs
Read the table left to right on every stem: compartment , resting CMAP , size of increment , pupils/autonomic , exposure .
Congenital myasthenic syndromes: one-paragraph contrast only
Congenital myasthenic syndromes (CMS) are genetic disorders of the NMJ (receptor, rapsyn, acetylcholinesterase, and other rare defects). Onset is typically infancy or childhood , without autoantibodies and without a toxin meal . Slow RNS can show a decrement . They belong on a clinician's differential for a floppy infant after botulism, metabolic disease, and anterior-horn disorders are considered. They are not outline item V.A.2.b. If the stem is an infant with constipation, poorly reactive pupils, and possible honey exposure, think infant botulism , not a CMS lecture. If the stem is lifelong fatigable weakness from birth without toxin exposure, CMS is a brief genetic contrast — then return to botulism, which is the topic you are being taught.
Worked botulism numbers
A previously well adult develops diplopia, dysarthria, and a dry mouth after home-canned vegetables. Pupils are dilated and sluggish. Ulnar ADM, taped and warm, is 2.0 mV at rest with a negative onset. Median and radial motor responses are also small. Sural and ulnar SNAPs are present . After 10 seconds of isometric exercise, ADM is 2.6 mV (about a 30 percent increment) with a small area rise. A 3 Hz train decrements. Fast RNS is not forced because the modest increment plus the clinical toxin picture already separates this from both typical MG (normal CMAP, no pupil freeze) and the section 10.2 LEMS example (1.5 → 4.0 mV). Report the pattern . Do not attach an invented official AAET percent that "makes" botulism.
- Exam traps
- Calling every low CMAP + increment LEMS without the toxin, pupil, and SNAP-spared cluster
- Expecting a LEMS-sized (often >60–100% teaching) increment in botulism
- Requiring absent SNAPs to diagnose botulism (they are typically spared )
- Labeling MG because of ptosis while ignoring pupils and a tiny resting CMAP
- Turning this section into a long CMS catalog
- Inventing an official unpublished AAET increment cutoff
- Forgetting foodborne versus wound versus infant as the three outline-ready clinical forms
Botulism in one line: SNARE cleavage, blocked ACh release, low CMAPs, modest increment, spared SNAPs, pupils and autonomic findings, foodborne/wound/infant exposure.